2017-003790-34: Drug disposition in the human colon: sampling optimization Geneesmiddelendispositie in het humane colon: optimalisering staalname |
|
|
| Ongoing | 4 | 10 | Europe | Modified-release tablet, Pentasa 500 mg tabletten met verlengde afgifte | KU Leuven - Drug Delivery and Disposition, KU Leuven | Healthy volunteers Gezonde vrijwilligers, Healthy volunteers Gezonde vrijwilligers, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10] | | | | |
2019-001009-26: Gastrointestinal behaviour of mesalazine in healthy volunteers Gastrointestinaal gedrag van mesalazine in gezonde vrijwilligers |
|
|
| Not yet recruiting | 4 | 10 | Europe | Modified-release tablet, Gastro-resistant tablet, Pentasa 500 mg tabletten met verlengde afgifte, Claversal 500 mg maagsapresistente tabletten, Mezavant 1.2 g maagsapresistente tabletten met verlengde afgifte, Nexiam, 40 mg Maagsap-resistente tabletten | KU Leuven - Drug Delivery and Disposition, KU Leuven | Healthy volunteers Gezonde vrijwilligers, Healthy volunteers Gezonde vrijwilligers, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10] | | | | |
| Recruiting | 2 | 260 | Europe | Mesalamine, Mesalazine, Pentasa sachet, 5-ASA, Placebo | Ann-Sofie Backman, The Swedish Research Council | Lynch Syndrome, Colon Cancer, Colon Neoplasm | 10/28 | 10/38 | | |